Slides
Page 1
Nikon FINANCIAL RESULTS The 1st Quarter of the Year Ending March 31 , 2027 NIKON CORPORATION August 6 , 2026
Page 2
2 1. Financial Results for the 1st Quarter of the Year Ending March 31, 2027 2. Forecast for the Year Ending March 31, 2027
Page 3
3 1st Quarter of the Year Ending March 31, 2027 : Summary Q1 Actual (YoY) • Revenue : ¥164.1B (Up ￥6.0B YoY) • Operating profit :-¥ 0.9B (Up ￥0.2B YoY) • Profit attributable to owners of parent : ¥ 1.2B (Down ￥8.2B YoY) • Revenue grew YoY on increased sales in business segments outside Imaging Products and FX tailwinds • Operating profit was flat YoY as profit tailwinds from increased sales and US tariff refunds (¥4.0B) were offset by lower sales volumes and higher memory prices in Imaging Products and ¥4.1B in inventory write-downs in Precision Equipment • Profit attributable to owners of parent turned positive due to gains from financial P&L and equity-method investments. However, it was down YoY as the disappearance of tax benefits (¥9.3B) booked in the previous year resulting from the resolution to dissolve and liquidate Nikon Metrology NV Note: Amounts in this statement are rounded down to the hundred millions of yen.
Page 4
4 Billions of Yen FY2026/3 Q1 FY2027/3 Q1 Change Actual (A) Actual (B) Amount (B)-(A) % (B)/(A) Revenue 158.1 164.1 +6.0 +3.8% Operating profit -1.1 -0.9 +0.2 -% vs Revenue -0.8% -0.6% +0.2P Profit before tax 0.7 1.5 +0.8 +88.8%% vs Revenue 0.5% 0.9% +0.4P Profit attributable to owners of parent 9.4 1.2 -8.2 -86.4% % vs Revenue 6.0% 0.8% -5.2P FCF -9.3 4.5 +13.8 - Exchange Rate: US$ ¥145 ¥160 Impact on Revenue +12.3 EURO ¥164 ¥185 Impact on Operating profit +0.7 1st Quarter of the Year Ending March 31, 2027 : Financial Highlights
Page 5
5 1st Quarter of the Year Ending March 31, 2027 : Performance by Segment FY2026/3 Q1 FY2027/3 Q1 Change Billions of Yen Actual (A) Actual (B) Amount (B)-(A) % (B)/(A) Imaging Products Business Revenue 80.0 72.9 -7.1 -8.8% Operating profit 11.1 8.1 -3.0 -27.5% % vs Revenue 14.0% 11.1% -2.9P Precision Equipment Business Revenue 33.8 38.2 +4.4 +13.2% Operating profit 1.8 -2.6 -4.4 - % vs Revenue 5.6% -6.9% -12.5P Healthcare Business Revenue 23.1 27.7 +4.6 +19.9% Operating profit -1.8 1.0 +2.8 - % vs Revenue -7.9% 3.8% +11.7P Industry Business Revenue 15.1 17.9 +2.8 +18.3% Operating profit 1.6 3.0 +1.4 +80.7% % vs Revenue 11.0% 16.8% +5.8P Digital Manufacturing Business Revenue 5.0 6.3 +1.3 +23.9% Operating profit -4.1 -2.1 +2.0 - % vs Revenue -82.2% -34.8% +47.4P Others (incl. Corporate expenses, etc.) Revenue 0.8 0.9 +0.1 +11.1% Operating profit -9.8 -8.3 +1.5 - Consolidated Revenue 158.1 164.1 +6.0 +3.8% Operating profit -1.1 -0.9 +0.2 - % vs Revenue -0.8% -0.6% +0.2P Note: FY2026/3 actual have been re-stated to reflect segmentation changes.
Page 6
6 1st Quarter of the Year Ending March 31, 2027 : Imaging Products Business FY2026/3 Q1 FY2027/3 Q1 Change Billions of Yen Actual (A) Actual (B) (B)-(A) Revenue 80.0 72.9 -7.1 Operating profit 11.1 8.1 -3.0 % vs Revenue 14.0% 11.1% -2.9P Digital Camera-Interchangeable Lens type (units: 1,000) 270 210 -60 Interchangeable Lens (units: 1,000) 370 310 -60 Q1 YoY : • Despite FX tailwinds, revenue was down on reduced sales of DCIL cameras and lenses driven by demand contraction mainly in China • Operating profit was down as reduced sales and higher memory prices outstripped FX tailwinds and US tariff refunds Note: FY2026/3 actual have been re-stated to reflect segmentation changes.
Page 7
7 1st Quarter of the Year Ending March 31, 2027 : Precision Equipment Business Q1 YoY : • Revenue grew as increased sales volumes of ArF dry lithography systems and other factors outstripped lower sales volumes of FPD lithography systems • Operating profit was down as the recognition of inventory write-downs (¥4.1B) outweighed profit growth on increased revenues Billions of Yen FY2026/3 Q1 FY2027/3 Q1 Change Actual (A) Actual (B) (B)-(A) Revenue 33.8 38.2 +4.4 Operating profit 1.8 -2.6 -4.4 % vs Revenue 5.6% -6.9% -12.5P FPD Lithography Systems (units) 7 5 -2 Semiconductor Lithography Systems New/Refurbished (units) 2/0 4/1 +2/+1
Page 8
8 1st Quarter of the Year Ending March 31, 2027 : Healthcare Business FY2026/3 Q1 FY2027/3 Q1 Change Billions of Yen Actual (A) Actual (B) (B)-(A) Revenue 23.1 27.7 +4.6 Operating profit -1.8 1.0 +2.8 % vs Revenue -7.9% 3.8% +11.7P Q1 YoY : • Revenue grew on FX tailwinds, a gradual recovery from previous year’s doldrums in the US academia market in Life Science Solutions, and solid sales trends in the US in Eye Care Solutions • Operating profit grew on increased revenues, US tariff refunds, and the decrease of one-time costs in Eye Care Solutions* *One-time costs in Eye Care Solutions: ¥0.5B (FY2026/3 Q1 actual), ¥0.1B (FY2027/3 Q1 actual)
Page 9
9 1st Quarter of the Year Ending March 31, 2027 : Industry Business FY2026/3 Q1 FY2027/3 Q1 Change Billions of Yen Actual (A) Actual (B) (B)-(A) Revenue 15.1 17.9 +2.8 Operating profit 1.6 3.0 +1.4 % vs Revenue 11.0% 16.8% +5.8P Q1 YoY : • Revenue and profit grew on increased sales and the pulling forward of demand for optical components, video measuring systems for electronic components and semiconductor applications, and other products Note: FY2026/3 actual have been re-stated to reflect segmentation changes.
Page 10
10 1st Quarter of the Year Ending March 31, 2027 : Digital Manufacturing Business FY2026/3 Q1 FY2027/3 Q1 Change Billions of Yen Actual (A) Actual (B) (B)-(A) Revenue 5.0 6.3 +1.3 Operating profit -4.1 -2.1 +2.0 % vs Revenue -82.2% -34.8% +47.4P Q1 YoY : • Revenue grew on strength in SLM's large-format metal 3D printers and FX tailwinds • Operating losses contracted on increased revenues, lower amortization (¥0.9B) of intangible assets, and benefits from restructuring
Page 11
11 1. Financial Results for the 1st Quarter of the Year Ending March 31, 2027 2. Forecast for the Year Ending March 31, 2027
Page 12
12 Forecast for 1H of the Year • Revenue : ¥336.0B (Revised downward ¥7.0B vs. previous forecast) • Operating profit : -¥ 5.5B (Revised upward ¥1.5B vs. previous forecast) • Profit attributable to owners of parent : -¥ 2.5B (Revised upward ¥0.5B vs. previous forecast) - Imaging Products: Revised downward revenue by ¥13.0B and operating profit by ¥3.0B to reflect a downward revision to the 1H sales plan, despite the reflection in Q1 of US tariff refunds - Healthcare: Revised upward revenue by ¥1.0B and operating profit by ¥2.0B to reflect Q1 results and US tariff refunds - Industry: Revised upward revenue by ¥5.0B and operating profit by ¥2.5B to reflect Q1 results Forecast for the First Half and Full Year of the Year Ending March 31, 2027 : Summary Forecast for the Full Year • Revenue : ¥732.0B (Revised downward ¥8.0B vs. previous forecast) • Operating profit : ¥ 11.0B (Revised upward ¥1.0B vs. previous forecast) • Profit attributable to owners of parent : ¥ 10.0B (Unchanged from previous forecast) - Full-year guidance was revised mainly to reflect revisions to 1H forecasts However, in Industry, we revised down 2H revenue by ¥1.0B and operating profit by ¥0.5B to reflect the pulling forward of demand from 2H for some products • Exchange Rate : US$ ¥156, EURO ¥181 (From Q2 onwards, US$ ¥155, EURO ¥180 (unchanged from previous forecast))
Page 13
13 Forecast for the Year Ending March 31, 2027 : Financial Highlights Billions of Yen FY2026/3 Previous Forecast New Forecast Change Change Actual (A) (May 8) (B) (Aug. 6) (C) (C)-(A) (C)-(B) Revenue 677.1 740.0 732.0 +54.9 -8.0 Operating profit -112.4 10.0 11.0 +123.4 +1.0 % vs Revenue -16.6% 1.4% 1.5% +18.1P +0.1P Profit before tax -106.5 14.0 14.5 +121.0 +0.5 % vs Revenue -15.7% 1.9% 2.0% +17.7P +0.1P Profit attributable to owners of parent -86.0 10.0 10.0 +96.0 - % vs Revenue -12.7% 1.4% 1.4% +14.1P - ROE -14.1% 1.7% 1.7% +15.8P - EPS -¥261.57 ¥30.36 ¥30.36 +¥291.93 - Annual Dividends ¥40 ¥20 ¥20 -¥20 - Exchange Rate: US$ ¥151 ¥155 ¥156 Impact on Revenue +16.9 +3.9 EURO ¥175 ¥180 ¥181 Impact on Operating profit +1.5 +0.5 Note: The numbers of issued shares assumed for EPS forecast calculation: approx. 329.4M shares for previous forecast (May 8) and approx. 329.4M shares for new forecast (Aug. 6).
Page 14
14 Previous Forecast New Forecast Change Billions of Yen (May 8) (A) (Aug. 6) (B) (B)-(A) 1H 2H Full Year 1H 2H Full Year 1H 2H Full Year Revenue 343.0 397.0 740.0 336.0 396.0 732.0 -7.0 -1.0 -8.0 Operating profit -7.0 17.0 10.0 -5.5 16.5 11.0 +1.5 -0.5 +1.0 % vs Revenue -2.0% 4.3% 1.4% -1.6% 4.2% 1.5% +0.4P -0.1P +0.1P Profit before tax -5.0 19.0 14.0 -4.0 18.5 14.5 +1.0 -0.5 +0.5 % vs Revenue -1.5% 4.8% 1.9% -1.2% 4.7% 2.0% +0.3P -0.1P +0.1P Profit attributable to owners of parent -3.0 13.0 10.0 -2.5 12.5 10.0 +0.5 -0.5 - % vs Revenue -0.9% 3.3% 1.4% -0.7% 3.2% 1.4% +0.2P -0.1P - ROE 1.7% 1.7% - EPS ¥30.36 ¥30.36 - Annual Dividends ¥20 ¥20 - Exchange Rate: US$ ¥155 ¥155 ¥155 ¥157 ¥155 ¥156 +¥2 ±¥0 +¥1 EURO ¥180 ¥180 ¥180 ¥183 ¥180 ¥181 +¥3 ±¥0 +¥1 Forecast for the Year Ending March 31, 2027 : Financial Highlights (Changes from Previous Forecast) Note: The numbers of issued shares assumed for EPS forecast calculation: approx. 329.4M shares for previous forecast (May 8) and approx. 329.4M shares for new forecast (Aug. 6).
Page 15
15 Forecast for the Year Ending March 31, 2027 : Forecast by Segment FY2026/3 Previous Forecast New Forecast Change Change Billions of Yen Actual (A) (May 8) (B) (Aug. 6) (C) (C)-(A) (C)-(B) Imaging Products Business Revenue 290.1 303.0 290.0 -0.1 -13.0 Operating profit 17.2 16.0 13.0 -4.2 -3.0 % vs Revenue 5.9% 5.3% 4.5% -1.4P -0.8P Precision Equipment Business Revenue 167.2 188.0 188.0 +20.8 - Operating profit -4.5 12.0 12.0 +16.5 - % vs Revenue -2.7% 6.4% 6.4% +9.1P - Healthcare Business Revenue 111.9 127.0 128.0 +16.1 +1.0 Operating profit 1.5 6.0 8.0 +6.5 +2.0 % vs Revenue 1.4% 4.7% 6.3% +4.9P +1.6P Industry Business Revenue 76.1 84.0 88.0 +11.9 +4.0 Operating profit 9.0 12.0 14.0 +5.0 +2.0 % vs Revenue 11.8% 14.3% 15.9% +4.1P +1.6P Digital Manufacturing Business Revenue 28.0 34.0 34.0 +6.0 - Operating profit -106.2 -4.0 -4.0 +102.2 - % vs Revenue -378.4% -11.8% -11.8% +366.6P - Others (incl. Corporate expenses, etc.) Revenue 3.6 4.0 4.0 +0.4 - Operating profit -29.3 -32.0 -32.0 -2.7 - Consolidated Revenue 677.1 740.0 732.0 +54.9 -8.0 Operating profit -112.4 10.0 11.0 +123.4 +1.0 % vs Revenue -16.6% 1.4% 1.5% +18.1P +0.1P Note: FY2026/3 actual have been re-stated to reflect segmentation changes.
Page 16
16 Forecast for the Year Ending March 31, 2027 : Forecast by Segment (Changes from Previous Forecast) Previous Forecast New Forecast Change Billions of Yen (May 8) (A) (Aug. 6) (B) (B)-(A) 1H 2H Full Year 1H 2H Full Year 1H 2H Full Year Imaging Products Business Revenue 143.0 160.0 303.0 130.0 160.0 290.0 -13.0 - -13.0 Operating profit 7.5 8.5 16.0 4.5 8.5 13.0 -3.0 - -3.0 Precision Equipment Business Revenue 89.0 99.0 188.0 89.0 99.0 188.0 - - - Operating profit 2.5 9.5 12.0 2.5 9.5 12.0 - - - Healthcare Business Revenue 58.0 69.0 127.0 59.0 69.0 128.0 +1.0 - +1.0 Operating profit 0.0 6.0 6.0 2.0 6.0 8.0 +2.0 - +2.0 Industry Business Revenue 34.0 50.0 84.0 39.0 49.0 88.0 +5.0 -1.0 +4.0 Operating profit 2.5 9.5 12.0 5.0 9.0 14.0 +2.5 -0.5 +2.0 Digital Manufacturing Business Revenue 17.0 17.0 34.0 17.0 17.0 34.0 - - - Operating profit -2.5 -1.5 -4.0 -2.5 -1.5 -4.0 - - - Others Revenue 2.0 2.0 4.0 2.0 2.0 4.0 - - - Operating profit -1.0 3.0 2.0 -1.0 3.0 2.0 - - - Corporate expenses, etc. Operating profit -16.0 -18.0 -34.0 -16.0 -18.0 -34.0 - - - Broken out: Expense related to investment in growth -7.5 -8.0 -15.5 -7.5 -8.0 -15.5 - - - Broken out: Expense for administration department -8.5 -8.5 -17.0 -8.5 -8.5 -17.0 - - - Broken out: Elimination of intersegment transactions 0.0 -1.5 -1.5 0.0 -1.5 -1.5 - - - Consolidated Revenue 343.0 397.0 740.0 336.0 396.0 732.0 -7.0 -1.0 -8.0 Operating profit -7.0 17.0 10.0 -5.5 16.5 11.0 +1.5 -0.5 +1.0
Page 17
17 Forecast for the Year Ending March 31, 2027 : Imaging Products Business • Vs. Previous Forecast: Revenue Down ¥13.0B, Operating Profit Down ¥3.0B • YoY: Revenue Down ¥0.1B, Operating Profit Down ¥4.2B 【Vs. Previous Forecast】 - Revised downward DCIL market size projections by 300 thousand units to reflect recent demand contraction mainly in China. Nevertheless, we expect the DCIL market to remain solid over the medium- to long-term - Revenue was revised downward by ¥13.0B, reflecting a reduction in 1H sales plan based on Q1 results and changes to market projections - Operating profit was revised downward by ¥3.0B on downward revisions to the 1H sales plan, despite US tariff refunds 【YoY】 - Revenue to be mostly flat YoY as FX tailwinds offset lower sales volumes - Operating profit to decline as lower sales volumes and higher memory prices outweigh FX tailwinds, the disappearance of one-time costs booked in the previous year, and US tariff refunds Revenue Operating Profit Digital Camera-Interchangeable Lens type (units: 1,000) Market Scale 7,040 7,000 6,700 Nikon 910 900 850 Interchangeable Lens (units:1,000) Market Scale 10,670 10,000 10,000 Nikon 1,300 1,300 1,250 290.1 303.0 290.0 17.2 16.0 13.0 0.0 100.0 200.0 300.0 400.0 FY2026/3 Actual FY2027/3 Forecast (May 8) FY2027/3 Forecast (Aug. 6) ¥400.0B Note: FY2026/3 actual have been re-stated to reflect segmentation changes.
Page 18
18 Forecast for the Year Ending March 31, 2027 : Precision Equipment Business Revenue Operating Profit • Vs. Previous Forecast: Unchanged • YoY: Revenue Up ¥20.8B, Operating Profit Up ¥16.5B 【Vs. Previous Forecast】 - Guidance remains unchanged because business trends in line with plan 【YoY】 - Revenue to grow as a decline in sales volumes of FPD lithography systems is expected to be offset by an increase in semiconductor ArF dry and immersion lithography systems sales volumes - Operating profit to grow on the disappearance of one-time costs from previous year and increased sales of ArF dry and immersion lithography systems - In Q1, we booked the first sale of our new ArF dry lithography system "NSR-S333F" FPD Lithography Systems (units) Market Scale 67 50 50(CY25/26) Nikon 32 27 27 Semiconductor Lithography Systems (New/Refurbished, units) Market Scale 570 580 580(CY25/26) Nikon 22/5 23/6 23/6 167.2 188.0 188.0 -4.5 12.0 12.0 -50.0 50.0 150.0 250.0 FY2026/3 Actual FY2027/3 Forecast (May 8) FY2027/3 Forecast (Aug. 6) ¥250.0B
Page 19
19 Forecast for the Year Ending March 31, 2027 : Healthcare Business Revenue Operating Profit 111.9 127.0 128.0 1.5 6.0 8.0 0.0 20.0 40.0 60.0 80.0 100.0 120.0 140.0 FY2026/3 Actual FY2027/3 Forecast (May 8) FY2027/3 Forecast (Aug. 6) ¥140.0B • Vs. Previous Forecast: Revenue Up ¥1.0B, Operating Profit Up ¥2.0B • YoY: Revenue Up ¥16.1B, Operating Profit Up ¥6.5B 【Vs. Previous Forecast】 - Revenue was revised upward by ¥1.0B to reflect Q1 results - Operating profit was revised upward by ¥2.0B on better-than-expected Q1 sales, US tariff refunds, and restrained expenses 【YoY】 - In Life Science Solutions, revenue to grow as stagnant sales to US academia are expected to recover, and increased sales are also expected in Asia and China - In Eye Care Solutions, performance to be in line with previous year as markets in Europe and the US trend solidly - In Contract Cell Development and Manufacturing, revenue to grow driven by expansion of existing projects - Operating profit to grow on increased revenues, the decrease of one-time costs in Eye Care Solutions*, and US tariff refunds * One-time costs in Eye Care Solutions: ¥2.9B (FY2026/3 actual), Approx. ¥1.0B (FY2027/3 forecast). See Contingent Liabilities (page 15) of our Consolidated Financial Results for details on the one- time costs.
Page 20
20 Forecast for the Year Ending March 31, 2027 : Industry Business Revenue Operating Profit 76.1 84.0 88.0 9.0 12.0 14.0 0.0 20.0 40.0 60.0 80.0 100.0 FY2026/3 Actual FY2027/3 Forecast (May 8) FY2027/3 Forecast (Aug. 6) ¥100.0B • Vs. Previous Forecast: Revenue Up ¥4.0B, Operating Profit Up ¥2.0B • YoY: Revenue Up ¥11.9B, Operating Profit Up ¥5.0B 【Vs. Previous Forecast】 - Revised upward revenue by ¥4.0B and operating profit by ¥2.0B to reflect Q1 results 【YoY】 - Revenue to grow on increased sales of EUV related components and other customized products - In optical parts and optical components, as well as the field of inspection and measurement equipment such as video measuring systems, X-ray and CT systems, we expect solid performance, supported by strengthened sales expansion efforts - FPD photomask substrates are expected to see a decline in reaction to the increase in sales in the previous year - Operating profit to grow on increased revenue and the disappearance of one-time costs incurred in the previous year, despite increased expenses resulting from strengthening sales activities and the launch of new products Note: FY2026/3 actual have been re-stated to reflect segmentation changes.
Page 21
21 28.0 34.0 34.0 -106.2 -4.0 -4.0 -40.0 -30.0 -20.0 -10.0 0.0 10.0 20.0 30.0 40.0 FY2026/3 Actual FY2027/3 Forecast (May 8) FY2027/3 Forecast (Aug. 6) Forecast for the Year Ending March 31, 2027 : Digital Manufacturing Business Revenue Operating Profit ¥40.0B • Vs. Previous Forecast: Unchanged • YoY: Revenue Up ¥6.0B, Operating Profit Up ¥102.2B 【Vs. Previous Forecast】 - Guidance remains unchanged because business trends in line with plan 【YoY】 - The overall market for metal 3D printers is expected to see increased demand for large-format metal 3D printers mainly in the defense and space segments - Revenue to grow on further sales expansion of SLM’s large-format metal 3D printers mainly in the defense and space segments - Operating losses to contract substantially on increased revenues, the disappearance of ¥91.3B in one-time costs from the previous year, a ¥2.6B reduction in amortization costs of intangible assets, and restructuring benefits - SLM to turn profitable in FY2027/3. Total segment to turn profitable in FY2028/3 Note: Intangible-asset amortization costs resulting from the Nikon SLM Solutions acquisition: ¥3.1B ( FY2026/3 results), ¥0.5B (FY2027/3 forecast) -120.0
Page 22
Reference Data
Page 23
23 Business Segments and Major Products Alignment Station [Litho Booster 1000] Photomask Substrates for FPD Optical Components Confocal Microscope System [AX/AX R] Ultra-Widefield Retinal Diagnostic Imaging System with Integrated UWF-Guided Swept Source OCT 「Silverstone」 Versatile Large-Envelope X-ray and CT System [VOXLS 40 C 450] Metal 3D Printer [NXG 600E] Multi-turn External Battery- Free Absolute Encoder [MAR-M700MFA] Digital Lithography System [DSP-100] ArF Immersion Scanner [NSR-S636E] Material Processing Machine [Lasermeister LM300A] 3D Scanner [Lasermeister SB100] Contract Material Processing Digital Cinema Camera [ZR] [NIKKOR Z 70-200mm f/2.8 VR S II] [V-RAPTOR [XE] Z Mount]Mirrorless Camera [Zf Silver] Contract Cell Development and Manufacturing Video Measuring System [NEXIV VMF-K Series] Laser Radar [APDIS MV5X] FPD Lithography System [FX-88SL] Segment Description Major products Imaging Products Business Digital camera-interchangeable lens type Interchangeable lens Digital cinema camera Precision Equipment Business FPD lithography system Semiconductor lithography system Digital lithography system Alignment station Healthcare Business Biological microscope (Life Science Solutions) Retinal diagnostic imaging system (Eye Care Solutions) Contract Cell Development and Manufacturing Industry Business EUV related components Optical parts, Optical components Encoders, Measuring and inspection systems Photomask substrates for FPD Digital Manufactur- ing Business Metal 3D printer Optical processing machine 3D scanner Contract material processing
Page 24
24 Billions of Yen FY2026/3 Q1 Q2 Q3 Q4 Full Year Details Imaging Products Business - - - -3.2 -3.2 Costs related to the sale of MRMC shares -3.2 Precision Equipment Business - +2.1 - -11.3 -9.2 Q2: Gain from transfer of business +2.9 and restructuring costs (optimization of service bases) -0.8 Q4: fixed-asset impairment losses -5.7, inventory write-downs -5.5 Healthcare Business -0.5 -0.4 -1.8 -0.1 -2.9 Q1-Q4: Eye Care Solutions investigation costs, etc. -1.4 Q3: Eye Care Solutions provision -1.4 Industry Business - - - -2.0 -2.0 Avonix* fixed assets impairment losses -1.4, restructuring costs -0.6 Digital Manufacturing Business - - -90.6 -0.6 -91.3 Q3: Impairment losses on fixed assets -90.6 Q4: Restructuring costs -0.6 Others (incl. Corporate expenses, etc.) -0.6 -0.5 -0.1 +4.3 +3.0 Q1-Q3: Expenses related to footprint reorganization -1.2 Q4: NCC** fixed-asset impairment losses -0.6, Capital gain on sale of idle land +4.9 Consolidated -1.1 +1.1 -92.5 -13.0 -105.6 The Year Ended March 31, 2026 : One-Time Profit/Losses by Segment * Avonix Imaging, Inc. was acquired in 2023 and is mainly in the business of the development and manufacture of X -ray and CT systems ** Nikon Creates (NCC) is mainly in the business of the planning, filming and production of next-generation imaging contents
Page 25
25 Billions of Yen FY2024/3 FY2025/3 FY2026/3 FY2027/3 Forecast Full Year Full Year 1H 2H Full Year 1H 2H Full Year Revenue 717.2 715.2 312.9 364.2 677.1 336.0 396.0 732.0 Operating profit 39.7 2.4 -4.8 -107.6 -112.4 -5.5 16.5 11.0 % vs Revenue 5.5% 0.3% -1.5% -29.5% -16.6% -1.6% 4.2% 1.5% Profit before tax 42.6 4.5 -5.2 -101.3 -106.5 -4.0 18.5 14.5 % vs Revenue 5.9% 0.6% -1.7% -27.8% -15.7% -1.2% 4.7% 2.0% Profit attributable to owners of parent 32.5 6.1 5.3 -91.3 -86.0 -2.5 12.5 10.0 % vs Revenue 4.5% 0.9% 1.7% -25.1% -12.7% -0.7% 3.2% 1.4% FCF -10.6 -21.7 -17.0 - ROE 5.0% 0.9% -14.1% 1.7% EPS ¥94.03 ¥17.86 -¥261.57 ¥30.36 Annual Dividends ¥50 ¥50 ¥40 ¥20 Exchange Rate: US$ ¥145 ¥153 ¥146 ¥156 ¥151 ¥157 ¥155 ¥156 EURO ¥157 ¥164 ¥168 ¥182 ¥175 ¥183 ¥180 ¥181 Forecast for the Year Ending March 31, 2027 : Financial Highlights Note: The numbers of issued shares assumed for EPS forecast calculation: approx . 329.4M shares
Page 26
26 Billions of Yen FY2026/3 FY2027/3 Change Actual (A) Forecast (B) (B)-(A) 1H 2H Full Year 1H 2H Full Year 1H 2H Full Year Revenue 312.9 364.2 677.1 336.0 396.0 732.0 +23.1 +31.8 +54.9 Operating profit -4.8 -107.6 -112.4 -5.5 16.5 11.0 -0.7 +124.1 +123.4 % vs Revenue -1.5% -29.5% -16.6% -1.6% 4.2% 1.5% -0.1P +33.7P +18.1P Profit before tax -5.2 -101.3 -106.5 -4.0 18.5 14.5 +1.2 +119.8 +121.0 % vs Revenue -1.7% -27.8% -15.7% -1.2% 4.7% 2.0% +0.5P +32.5P +17.7P Profit attributable to owners of parent 5.3 -91.3 -86.0 -2.5 12.5 10.0 -7.8 +103.8 +96.0 % vs Revenue 1.7% -25.1% -12.7% -0.7% 3.2% 1.4% -2.4P +28.3P +14.1P ROE -14.1% 1.7% +15.8P EPS -¥261.57 ¥30.36 +¥291.93 Annual Dividends ¥40 ¥20 -¥20 Exchange Rate: US$ ¥146 ¥156 ¥151 ¥157 ¥155 ¥156 +¥11 -¥1 +¥5 EURO ¥168 ¥182 ¥175 ¥183 ¥180 ¥181 +¥15 -¥2 +¥6 Forecast for the Year Ending March 31, 2027 : Financial Highlights Note: The numbers of issued shares assumed for EPS forecast calculation: approx . 329.4M shares
Page 27
27 Forecast for the Year Ending March 31, 2027 : Forecast by Segment FY2026/3 FY2027/3 Change Billions of Yen Actual (A) Forecast (B) (B)-(A) 1H 2H Full Year 1H 2H Full Year 1H 2H Full Year Imaging Products Business Revenue 145.0 145.1 290.1 130.0 160.0 290.0 -15.0 +14.9 -0.1 Operating profit 15.4 1.8 17.2 4.5 8.5 13.0 -10.9 +6.7 -4.2 Precision Equipment Business Revenue 69.8 97.4 167.2 89.0 99.0 188.0 +19.2 +1.6 +20.8 Operating profit 3.0 -7.5 -4.5 2.5 9.5 12.0 -0.5 +17.0 +16.5 Healthcare Business Revenue 51.2 60.7 111.9 59.0 69.0 128.0 +7.8 +8.3 +16.1 Operating profit 0.3 1.2 1.5 2.0 6.0 8.0 +1.7 +4.8 +6.5 Industry Business Revenue 35.0 41.1 76.1 39.0 49.0 88.0 +4.0 +7.9 +11.9 Operating profit 4.9 4.1 9.0 5.0 9.0 14.0 +0.1 +4.9 +5.0 Digital Manufacturing Business Revenue 9.8 18.2 28.0 17.0 17.0 34.0 +7.2 -1.2 +6.0 Operating profit -8.9 -97.3 -106.2 -2.5 -1.5 -4.0 +6.4 +95.8 +102.2 Others Revenue 1.8 1.8 3.6 2.0 2.0 4.0 +0.2 +0.2 +0.4 Operating profit -0.5 1.9 1.4 -1.0 3.0 2.0 -0.5 +1.1 +0.6 Corporate expenses, etc. Operating profit -19.0 -11.7 -30.7 -16.0 -18.0 -34.0 +3.0 -6.3 -3.3 Broken out: Expense related to investment in growth -8.4 -9.4 -17.8 -7.5 -8.0 -15.5 +0.9 +1.4 +2.3 Broken out: Expense for administration department -8.9 -4.3 -13.2 -8.5 -8.5 -17.0 +0.4 -4.2 -3.8 Broken out: Elimination of intersegment transactions -1.7 2.0 0.3 0.0 -1.5 -1.5 +1.7 -3.5 -1.8 Consolidated Revenue 312.9 364.2 677.1 336.0 396.0 732.0 +23.1 +31.8 +54.9 Operating profit -4.8 -107.6 -112.4 -5.5 16.5 11.0 -0.7 +124.1 +123.4 Note: FY2026/3 actual have been re-stated to reflect segmentation changes.
Page 28
28 1st Quarter of the Year Ending March 31, 2027 : Quarterly Performance by Segment FY2026/3 FY2027/3 Billions of Yen Q1 Q2 Q3 Q4 Q1 Imaging Products Business Revenue 80.0 65.0 84.1 61.0 72.9 Operating profit 11.1 4.3 6.0 -4.2 8.1 Precision Equipment Business Revenue 33.8 36.0 34.8 62.6 38.2 Operating profit 1.8 1.2 -2.4 -5.1 -2.6 Healthcare Business Revenue 23.1 28.1 27.8 32.9 27.7 Operating profit -1.8 2.1 -0.9 2.1 1.0 Industry Business Revenue 15.1 19.9 16.7 24.4 17.9 Operating profit 1.6 3.3 1.2 2.9 3.0 Digital Manufacturing Business Revenue 5.0 4.8 6.8 11.4 6.3 Operating profit -4.1 -4.8 -94.5 -2.8 -2.1 Others Revenue 0.8 1.0 0.9 0.9 0.9 Operating profit -0.2 -0.3 -1.0 2.9 0.3 Corporate expenses, etc. Operating profit -9.6 -9.4 -7.1 -4.6 -8.6 Broken out: Expense related to investment in growth -4.1 -4.3 -4.2 -5.2 -3.1 Broken out: Expense for administration department -4.0 -4.9 -4.1 -0.2 -3.5 Broken out: Elimination of intersegment transactions -1.4 -0.3 1.3 0.7 -1.9 Consolidated Revenue 158.1 154.8 171.0 193.2 164.1 Operating profit -1.1 -3.7 -98.8 -8.8 -0.9 Note: FY2026/3 actual have been re-stated to reflect segmentation changes.
Page 29
29 1st Quarter of the Year Ending March 31, 2027 : Financial Position Note: Cash and cash equivalents exclude time deposits with maturities of three months or more. Equity ratio is the ratio of equity attributable to owners of parent to total assets. Cash & cash equivalents Trade & other receivables Inventories Other current financial /current assets Non-current assets Other liabilities Total equity Interest-bearing debt Advances received 490.2 507.5 428.5 445.4 23.6 28.6 28.1 34.4 307.5 321.5 332.8 338.2 125.4 115.9 127.4 121.9 163.5 164.7 158.0 157.0 1,110.5 1,138.4 1,075.0 1,097.1 0 250 500 750 1,000 1,250 25/3 25/6 26/3 26/6 ¥1,250B 639.2 642.7 588.1 594.7 189.4 178.3 179.6 185.7 213.6 235.3 239.8 238.9 68.1 82.0 67.3 77.6 1,110.5 1,138.4 1,075.0 1,097.1 0 250 500 750 1,000 1,250 25/3 25/6 26/3 26/6 ¥1,250B Equity ratio 57.4% 56.3% 54.6% 54.1% ASSET LIABILITIES/EQUITY
Page 30
30 Capital Expenditures, Depreciation & Amortization, and Inventories Note: Capital expenditures include right-of-use assets. Depreciation & amortization include right-of-use assets, depreciation of property, plant and equipment and amortization of intangible assets obtained by business combination. Imaging Products Precision Equipment Healthcare 42.1 70.7 69.3 59.8 75.0 29.0 35.6 44.1 43.0 43.0 0 10 20 30 40 50 60 70 80 23/3 24/3 25/3 26/3 27/3 Forecast Capital expenditures Depreciation & amortization 98.2 94.7 101.1 102.8 116.7 128.9 127.4 125.1 24.3 25.0 26.2 27.025.3 25.7 27.0 28.612.1 13.2 19.6 20.730.7 33.8 31.2 33.8307.5 321.5 332.8 338.2 0 50 100 150 200 250 300 350 25/3 25/6 26/3 26/6 ¥80B ¥350B Digital Manufacturing Industry CAPITAL EXPENDITURES, DEPRECIATION & AMORTIZATION BREAKDOWN OF INVENTORIES Others Note: FY2026/3 actual have been re-stated to reflect segmentation changes.
Page 31
31 27/3 15% 25.4 26% 42.2 16% 27.0 25% 40.9 17% 28.4 26/3 14% 21.9 26% 41.5 18% 28.4 26% 40.8 16% 25.4 27/3 44% 72.9 23% 38.2 17% 27.7 11% 17.9 4% 6.3 1% 0.9 26/3 51% 80.021% 33.8 15% 23.1 10% 15.1 3% 5.0 1% 0.8 1st Quarter of the Year Ending March 31, 2027 : Revenue Breakdown Japan United States Europe China Others Digital Manufacturing Healthcare Precision Equipment Imaging Products Industry BY REGIONBY SEGMENT Billions of YenBillions of Yen Others Note: The outside and inside circles show the breakdown of FY2027/3 revenue of ¥164.1B and FY2026/3 revenue of ¥158.1B, respectively. Note: FY2026/3 actual have been re-stated to reflect segmentation changes.
Page 32
32 27/3 Forecast 33% 24.5 28% 20.5 12% 8.5 7% 5.0 9% 6.5 12% 8.5 26/3 32% 24.4 28% 21.6 10% 7.9 6% 4.7 10% 7.5 14% 10.8 Healthcare Imaging Products Billions of Yen Corporate (Undistributed) Digital Manufacturing Precision Equipment 70.0 76.5 80.1 77.1 73.5 11.2% 10.7% 11.2% 11.4% 10.0% 5.0% 10.0% 15.0% 20.0% 0 10 20 30 40 50 60 70 80 90 23/3 24/3 25/3 26/3 27/3 Forecast R&D Expenditures R&D vs Revenue (%) ¥90B Industry R&D EXPENDITURES R&D EXPENDITURES BREAKDOWN Forecast for the Year Ending March 31, 2027 : R&D Expenditures Note: R&D expenditures include capitalization of some development expenditures. Note: FY2026/3 actual have been re-stated to reflect segmentation changes.
Page 33
33 Cash Flow History -56.2 49.9 54.9 39.7 2.4 -112.4 4.9 31.3 0.0 30.7 48.2 -4.4 18.0 -0.3 -112.1 -41.4 -69.9 -12.6 -4.9 -26.1 -56.2 -8.9 -19.8 0.8 22.9 30.9 -112.1 -10.6 -21.7 -17.0 -150 -100 -50 0 50 100 Operating Profit Cash Flows from operating activities Net cash used in investing activities Net cash used in financing activities Free cash flow ¥100B 21/3 22/3 23/3 24/3 25/3 26/3 Note: FCF + CF from financing activities + Effect of exchange rate changes on cash and cash equivalents = net increase (decrease) i n cash and cash equivalents
Page 34
34 Imaging Products Business : Sales Units 200 170 210 120 220 170 250 160 230 180 260 180 270 210 260 170 210 340 270 320 230 330 280 370 270 370 280 370 290 370 300 360 270 310 0 100 200 300 400 500 DCIL(Digital Camera-Interchangeable Lens Type) Interchangeable Lens 500K Units SALES IN UNITS BY PRODUCT CATEGORY
Page 35
35 ArF immersion ArF dry KrF i-line, etc. G7/8 G5/6 17 11 16 17 10 10 5 1 22 15 16 16 7 4 1 1 29 16 38 32 27 27 0 20 40 60 23/3 Actual 24/3 Actual 25/3 Actual 26/3 Actual 27/3 Forecast (May 8) 27/3 Forecast (Aug. 6) 系列1 系列2 系列3 27 23 18 20 17 17 6 4 2 4 2 2 8 8 5 3 7 7 4 11 3 3 3 45 46 28 27 29 29 0 20 40 60 23/3 Actual 24/3 Actual 25/3 Actual 26/3 Actual 27/3 Forecast (May 8) 27/3 Forecast (Aug. 6) 系列1 系列2 系列3 系列460 Units 60 Units FPD LITHOGRAPHY SYSTEMS SALES BY GENERATION Note: “i-line, etc.” part in numbers of semiconductor lithography systems sales include sales numbers of the “Mini Step & Repeat Exposure System.” The unit sales of new semiconductor lithography systems are 27 units in FY2023/3, 31 units in FY2024/3, 18 units in FY2025/3, 22 units in FY2026/3, and 23 units (forecast) in FY2027/3. SEMICONDUCTOR LITHOGRAPHY SYSTEMS SALES BY TECHNOLOGY (INCL. REFURBISHED) G7/8 G5/6 G10.5 i-line, etc. KrF ArF dry ArF immersion Forecast for the Year Ending March 31, 2027 : Precision Equipment Business Sales Units G10.5
Page 36
36 Precision Equipment Business : Sales Units 4 5 3 5 2 4 5 5 1 3 7 6 4 4 3 1 1 3 1 2 8 7 5 1 4 3 7 5 3 2 2 1 3 7 6 6 10 2 2 7 5 7 9 10 12 7 8 7 10 5 0 5 10 15 20 G5/6 G7/8 G10.5 FPD LITHOGRAPHY SYSTEMS SALES IN UNITS BY GENERATION 20 units
Page 37
37 Precision Equipment Business : Sales Units SEMICONDUCTOR LITHOGRAPHY SYSTEMS SALES IN UNITS BY TECHNOLOGY（INCL. REFURBISHED） 4 6 5 12 1 4 7 11 4 3 11 2 6 3 9 2 3 1 1 1 1 3 2 4 1 1 2 5 1 2 2 3 2 2 1 1 2 2 1 2 1 2 4 2 3 1 2 8 8 10 19 4 10 12 20 4 6 2 16 2 7 3 15 5 0 5 10 15 20 i-line, etc. KrF ArF dry ArF immersion 20 units Note: “i-line, etc.” part in numbers of semiconductor lithography systems sales include sales numbers of the “Mini Step & Repeat Exposure System.”
Page 38
38 Exchange Rate Financial Impact from Fluctuation by 1 yen FY2027/3 Forecast for Q2～Q4 Revenue Q2～Q4 Operating Profit Q2～Q4 US$ ¥155 Approx. ¥1.8B Approx. ¥0.3B EURO ¥180 Approx. ¥0.5B Approx. ¥0.2B Forecast for the Year Ending March 31, 2027 : Foreign Exchange Impact Note: The foreign exchange impact above is made on the assumption that emerging-market currencies move according to the influence of U S$ and EURO.
Page 39
Disclaimer Regarding Forecast and Projections Forward-looking statements for earnings and other performance data contained herein are based on information currently available to the Company, and all potential risks and uncertainties are taken into account. The Company asks that investors understand that changes in conditions may cause actual performance to significantly differ from these projections.